theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Palliative Medicine

General Geriatric Medicine   

Questions discussed in this category


How do you determine whether to continue anti-dementia medications (such as cholinesterase inhibitors) for patients with dementia when enrolling in hospice?
3 Answers available

What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
1 Answer available
2529725296


Papers discussed in this category


The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2018-02
A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.

JAMA internal medicine, 2025 May 01
Continued Use of Cholinesterase Inhibitors and Memantine in Hospice.

Alzheimer's & dementia (New York, N. Y.), 2022 Jan 31
CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia.

The Medical journal of Australia, 2019 Feb 16
Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.

Related Topics in Palliative Medicine

  • Hospital Medicine
  • General Internal Medicine
  • Primary Care
  • Geriatric Medicine
  • General Hospital Medicine
  • Critical Care
  • General Geriatric Medicine
  • Medical Oncology
  • Dementia
  • Pulmonology

Copyright © 2025 theMednet
All Rights Reserved.